{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T16:05:13Z","timestamp":1775491513881,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:00:00Z","timestamp":1794355200000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K11648"],"award-info":[{"award-number":["25K11648"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019356","name":"SGH Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019356","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.leukres.2025.108134","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:20:54Z","timestamp":1762388454000},"page":"108134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Differential impact of graft-versus-host disease on post-transplant outcomes of chronic myelomonocytic leukemia according to transplant procedures"],"prefix":"10.1016","volume":"159","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1438-3623","authenticated-orcid":false,"given":"Hidehiro","family":"Itonaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1661-8273","authenticated-orcid":false,"given":"Machiko","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6426-6770","authenticated-orcid":false,"given":"Shuhei","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunobu","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1604-7220","authenticated-orcid":false,"given":"Yutaka","family":"Shimazu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5952-5926","authenticated-orcid":false,"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8661-3179","authenticated-orcid":false,"given":"Noriko","family":"Doki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"Asada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mineo","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5935-0385","authenticated-orcid":false,"given":"Makoto","family":"Yoshimitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Ichinohe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4404-2870","authenticated-orcid":false,"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7780-4459","authenticated-orcid":false,"given":"Takayoshi","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.leukres.2025.108134_bib1","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.leukres.2025.108134_bib2","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.108134_bib3","unstructured":"Khoury J., Solary E., Abla O., Akkari Y., Alaggio R., Apperley J., et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms."},{"issue":"3","key":"10.1016\/j.leukres.2025.108134_bib4","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1182\/blood.V99.3.840","article-title":"Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients","volume":"99","author":"Onida","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.108134_bib5","first-page":"107","article-title":"Chronic myelomonocytic leukemia","volume":"142","author":"Beran","year":"2008","journal-title":"Cancer Trear Res"},{"issue":"2","key":"10.1016\/j.leukres.2025.108134_bib6","first-page":"139","article-title":"Intensive chemotherapy for patients with high-risk myelodysplastic syndrome","volume":"72","author":"Beran","year":"2000","journal-title":"Int J. Hematol."},{"issue":"4","key":"10.1016\/j.leukres.2025.108134_bib7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.leukres.2007.08.004","article-title":"Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML)","volume":"32","author":"Wijermans","year":"2008","journal-title":"Leuk. Res"},{"issue":"7","key":"10.1016\/j.leukres.2025.108134_bib8","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/leu.2014.85","article-title":"A multi-centre phase 2 study of azacitidine in chronic myelomonocytic leukaemia","volume":"28","author":"Drummond","year":"2014","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.leukres.2025.108134_bib9","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1200\/JCO.22.00437","article-title":"Decitabine versus hydroxyurea for advanced proliferative chronic myelomonocytic leukemia: results of a randomized phase III trial within the EMSCO network","volume":"41","author":"Itzykson","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.leukres.2025.108134_bib10","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1158\/1078-0432.CCR-21-0935","article-title":"Integrated human and murine clinical study establishes clinical efficacy of ruxolitinib in chronic myelomonocytic leukemia","volume":"27","author":"Hunter","year":"2021","journal-title":"Clin. Cancer Res"},{"issue":"7","key":"10.1016\/j.leukres.2025.108134_bib11","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/blood.2019004352","article-title":"Phase 1 study of lenzilumab, a recombinant anti-human GM-CSF antibody, for chronic myelomonocytic leukemia","volume":"136","author":"Patnaik","year":"2020","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.leukres.2025.108134_bib12","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood.2024025648","article-title":"Perspectives on drug development in chronic myelomonocytic leukemia: changing the paradigm","volume":"144","author":"Hunter","year":"2024","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2025.108134_bib13","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.bbmt.2010.09.018","article-title":"Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbidities","volume":"17","author":"Eissa","year":"2011","journal-title":"Biol. Blood Marrow Transpl."},{"issue":"5","key":"10.1016\/j.leukres.2025.108134_bib14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/ejh.12073","article-title":"Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire","volume":"90","author":"Park","year":"2013","journal-title":"Eur. J. Haematol."},{"issue":"2","key":"10.1016\/j.leukres.2025.108134_bib15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/bjh.13576","volume":"171","author":"Symeonidis","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2025.108134_bib16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.leukres.2015.12.009","article-title":"Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: a nationwide retrospective study","volume":"41","author":"Itonaga","year":"2016","journal-title":"Leuk. Res"},{"issue":"4","key":"10.1016\/j.leukres.2025.108134_bib17","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bbmt.2017.11.016","article-title":"Prognostic impact of donor source on allogeneic hematopoietic stem cell transplantation outcomes in adults with chronic myelomonocytic leukemia: a nationwide retrospective analysis in Japan","volume":"24","author":"Itonaga","year":"2018","journal-title":"Biol. Blood Marrow Transpl."},{"issue":"11","key":"10.1016\/j.leukres.2025.108134_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41408-020-00387-y","article-title":"Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia","volume":"10","author":"Pophali","year":"2020","journal-title":"Blood Cancer J."},{"issue":"6","key":"10.1016\/j.leukres.2025.108134_bib19","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/s41409-024-02223-4","article-title":"Updated comparable efficacy of cord blood transplantation for chronic myelomonocytic leukaemia: a nationwide study","volume":"59","author":"Kurosawa","year":"2024","journal-title":"Bone Marrow Transpl."},{"issue":"1","key":"10.1016\/j.leukres.2025.108134_bib20","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3324\/haematol.2021.280203","article-title":"The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis","volume":"108","author":"Mei","year":"2023","journal-title":"Hematologica"},{"issue":"22","key":"10.1016\/j.leukres.2025.108134_bib21","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1182\/blood.2023023476","article-title":"Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee","volume":"143","author":"Onida","year":"2024","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2025.108134_bib22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ajh.27150","article-title":"Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT","volume":"99","author":"Rov\u00f3","year":"2024","journal-title":"Am. J. Hematol."},{"issue":"12","key":"10.1016\/j.leukres.2025.108134_bib23","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.3324\/haematol.2023.283426","article-title":"Haploidentical donor hematopoietic cell transplantation for myelodysplastic\/myeloproliferative overlap neoplasms: results from a North American collaboration","volume":"108","author":"Jain","year":"2023","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.leukres.2025.108134_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12185-015-1894-x","article-title":"Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data)","volume":"103","author":"Atsuta","year":"2016","journal-title":"Int J. Hematol."},{"issue":"1","key":"10.1016\/j.leukres.2025.108134_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12185-015-1907-9","article-title":"Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation","volume":"103","author":"Kanda","year":"2016","journal-title":"Int. J. Hematol."},{"issue":"3","key":"10.1016\/j.leukres.2025.108134_bib26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1532\/IJH97.06239","article-title":"Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System","volume":"86","author":"Atsuta","year":"2007","journal-title":"Int. J. Hematol."},{"issue":"3","key":"10.1016\/j.leukres.2025.108134_bib27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol. Blood Marrow Transpl."},{"issue":"6","key":"10.1016\/j.leukres.2025.108134_bib28","first-page":"825","article-title":"Consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1994","journal-title":"Bone Marrow Transpl."},{"issue":"3","key":"10.1016\/j.leukres.2025.108134_bib29","first-page":"250","article-title":"Chronic graft-versus-host disease and other late complications of bone marrow transplantation","volume":"28","author":"Sullivan","year":"1991","journal-title":"Semin. Hematol."},{"issue":"6","key":"10.1016\/j.leukres.2025.108134_bib30","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat. Med."},{"issue":"446","key":"10.1016\/j.leukres.2025.108134_bib31","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J. Am. Stat. Assoc."},{"issue":"1","key":"10.1016\/j.leukres.2025.108134_bib32","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/bimj.200900076","article-title":"Competing risks and time-dependent covariates","volume":"52","author":"Cortese","year":"2010","journal-title":"Biom. J."},{"issue":"3","key":"10.1016\/j.leukres.2025.108134_bib33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transpl."},{"issue":"24","key":"10.1016\/j.leukres.2025.108134_bib34","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1158\/1078-0432.CCR-20-1104","article-title":"Effects of acute and chronic graft-versus-myelodysplastic syndrome on long-term outcomes following allogeneic hematopoietic cell transplantation","volume":"26","author":"Konuma","year":"2020","journal-title":"Clin. Cancer Res"},{"issue":"4","key":"10.1016\/j.leukres.2025.108134_bib35","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1200\/JCO.2007.11.1641","article-title":"Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival","volume":"26","author":"Valc\u00e1rcel","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.leukres.2025.108134_bib36","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1038\/leu.2014.145","article-title":"Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis","volume":"28","author":"Stern","year":"2014","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.leukres.2025.108134_bib37","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.bbmt.2012.06.014","article-title":"Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning","volume":"18","author":"Weisdorf","year":"2012","journal-title":"Biol. Blood Marrow Transpl."},{"issue":"13","key":"10.1016\/j.leukres.2025.108134_bib38","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1182\/blood-2008-07-163212","article-title":"The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation","volume":"113","author":"Ringd\u00e9n","year":"2009","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2025.108134_bib39","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/sj.leu.2403343","article-title":"Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate","volume":"18","author":"Kanda","year":"2004","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.leukres.2025.108134_bib40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/bjh.16540","article-title":"Impact of graft-versus-host disease and graft-versus-leukemia effect based on minimal residual disease in Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"190","author":"Akahoshi","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"17","key":"10.1016\/j.leukres.2025.108134_bib41","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1158\/1078-0432.CCR-20-4856","article-title":"Differential effect of graft-versus-host disease on survival in acute leukemia according to donor type","volume":"27","author":"Konuma","year":"2021","journal-title":"Clin. Cancer Res"},{"issue":"19","key":"10.1016\/j.leukres.2025.108134_bib42","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa1917635","article-title":"Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease","volume":"382","author":"Zeiser","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.leukres.2025.108134_bib43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12185-015-1915-9","article-title":"Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II\/III study","volume":"103","author":"Muroi","year":"2016","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.leukres.2025.108134_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2021.101417","article-title":"The response-guided ATG treatment provides a survival benefit and KPS recovery for patients with steroid refractory acute GVHD: The Nagasaki Transplant Group Experience","volume":"67","author":"Fujioka","year":"2021","journal-title":"Transpl. Immunol."},{"issue":"25","key":"10.1016\/j.leukres.2025.108134_bib45","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1182\/blood-2018-01-822957","article-title":"MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD","volume":"131","author":"Major-Monfried","year":"2018","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2025.108134_bib46","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1182\/blood.2024025106","article-title":"Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD","volume":"144","author":"Akahoshi","year":"2024","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2025.108134_bib47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41409-023-02142-w","article-title":"Effect of graft-versus-host disease on outcomes of HLA-haploidentical peripheral blood transplantation using post-transplant cyclophophamide","volume":"59","author":"Shimomura","year":"2024","journal-title":"Bone Marrow Transpl."},{"issue":"6","key":"10.1016\/j.leukres.2025.108134_bib48","first-page":"365.e1","article-title":"Effect of graft-versus-host disease on post-transplantation outcomes following single cord blood transplantation compared with haploidentical transplantation with post-transplantation cyclophosphamide for adult acute myeloid leukemia","volume":"29","author":"Konuma","year":"2023","journal-title":"Transpl. Cell Ther."},{"issue":"17","key":"10.1016\/j.leukres.2025.108134_bib49","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1182\/blood-2016-12-754796","article-title":"Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation","volume":"129","author":"Yoshizato","year":"2017","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2025.108134_bib50","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2016-05-714030","article-title":"Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia","volume":"128","author":"Elena","year":"2016","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212625006241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212625006241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T11:06:56Z","timestamp":1773313616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212625006241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":50,"alternative-id":["S0145212625006241"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2025.108134","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential impact of graft-versus-host disease on post-transplant outcomes of chronic myelomonocytic leukemia according to transplant procedures","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2025.108134","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108134"}}